SCHEMBL27620786

SCHEMBL27620786

CCCCc1c(CCBr)nc(Cl)nc1-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 3/20 0.43
LMNA P02545 2/20 0.43
MAPT P10636 2/20 0.43
GLA P06280 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GPR84 Q9NQS5 1/20 0.40
GCGR P47871 2/20 0.39
MEN1 O00255 2/20 0.39
CYP1A2 P05177 2/20 0.39
KMT2A Q03164 2/20 0.39
TACR3 P29371 2/20 0.38
CYP2C9 P11712 1/20 0.38
CRHBP P24387 1/20 0.38
CYP2C19 P33261 1/20 0.38
CRHR2 Q13324 1/20 0.38
TLR8 Q9NR97 3/20 0.38
HSD11B1 P28845 1/20 0.38
ERBB2 P04626 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL647979 0.90 KDM4E (0.44) KDM4EALDH1A1LMNAMAPTGLA
SCHEMBL648635 0.81 KDM4E (0.49) KDM4EALDH1A1LMNAMAPTGLA
SCHEMBL28754990 0.80 HSD11B1 (0.39) ALDH1A1MAPTGPR84GCGRTACR3
SCHEMBL650101 0.74 ERBB2 (0.42) GPR84GCGRTACR3TLR8HSD11B1
SCHEMBL25720193 0.71 KDM4E (0.61) KDM4EALDH1A1LMNAMAPTGLA
SCHEMBL12495846 0.70 TLR8 (0.54) KDM4EALDH1A1LMNAGLAHPGD
SCHEMBL12495851 0.69 TLR8 (0.60) GPR84TLR8HSD11B1PSMB5
SCHEMBL23070173 0.68 KDM4E (0.65) KDM4EALDH1A1LMNAMAPTGLA
SCHEMBL28499792 0.67 KDM4E (0.55) KDM4EALDH1A1LMNAMAPTGLA
SCHEMBL647774 0.67 HSD11B1 (0.43) ALDH1A1MAPTGPR84GCGRTLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1646497-A Novel arylimidazoles and related compounds as modulators of the C5a receptor NEUROGEN CORP (US) 2005-07-27 CN disclosed